View in EDS

Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan.

Saved in:
Bibliographic Details
Title: Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan.
Authors: Aizawa Y; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan. Electronic address: yaizawa@med.niigata-u.ac.jp., Shobugawa Y; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Department of Active Ageing, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Tachikawa J; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan., Ikuse T; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan., Shin C; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Shin Pediatric Clinic, Niigata, Japan., Ikarashi T; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Ikarashi Pediatric and Allergy Clinic, Niigata, Japan., Okugawa T; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Okugawa Pediatric Clinic, Niigata, Japan., Otsuka T; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Otsuka Pediatric Clinic, Niigata, Japan., Sasagawa F; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Sasagawa Pediatric Clinic, Niigata, Japan., Sakauchi M; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Sakauchi Pediatric Clinic, Niigata, Japan., Sato M; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Sato Pediatric Clinic, Niigata, Japan., Ino H; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Seikyou Pediatric Clinic, Niigata, Japan., Ota M; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Ota Kids and Allergy Clinic, Niigata, Japan., Kon M; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Virology Section, Niigata Prefectural Institute of Public Health and Environmental Science, Niigata, Japan., Saitoh A; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan.
Source: Vaccine [Vaccine] 2026 Apr 19; Vol. 79, pp. 128474. Date of Electronic Publication: 2026 Mar 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41844090
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aizawa+Y%22">Aizawa Y</searchLink>; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan. Electronic address: yaizawa@med.niigata-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Shobugawa+Y%22">Shobugawa Y</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Department of Active Ageing, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Tachikawa+J%22">Tachikawa J</searchLink>; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Ikuse+T%22">Ikuse T</searchLink>; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Shin+C%22">Shin C</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Shin Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Ikarashi+T%22">Ikarashi T</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Ikarashi Pediatric and Allergy Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Okugawa+T%22">Okugawa T</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Okugawa Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Otsuka+T%22">Otsuka T</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Otsuka Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Sasagawa+F%22">Sasagawa F</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Sasagawa Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Sakauchi+M%22">Sakauchi M</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Sakauchi Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+M%22">Sato M</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Sato Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Ino+H%22">Ino H</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Seikyou Pediatric Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Ota+M%22">Ota M</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Ota Kids and Allergy Clinic, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Kon+M%22">Kon M</searchLink>; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan; Virology Section, Niigata Prefectural Institute of Public Health and Environmental Science, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Saitoh+A%22">Saitoh A</searchLink>; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Pediatric COVID-19 Vaccine Study Group in Niigata, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Apr 19; Vol. 79, pp. 128474. <i>Date of Electronic Publication: </i>2026 Mar 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41844090
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2026.128474
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 128474
    Titles:
      – TitleFull: Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aizawa Y
      – PersonEntity:
          Name:
            NameFull: Shobugawa Y
      – PersonEntity:
          Name:
            NameFull: Tachikawa J
      – PersonEntity:
          Name:
            NameFull: Ikuse T
      – PersonEntity:
          Name:
            NameFull: Shin C
      – PersonEntity:
          Name:
            NameFull: Ikarashi T
      – PersonEntity:
          Name:
            NameFull: Okugawa T
      – PersonEntity:
          Name:
            NameFull: Otsuka T
      – PersonEntity:
          Name:
            NameFull: Sasagawa F
      – PersonEntity:
          Name:
            NameFull: Sakauchi M
      – PersonEntity:
          Name:
            NameFull: Sato M
      – PersonEntity:
          Name:
            NameFull: Ino H
      – PersonEntity:
          Name:
            NameFull: Ota M
      – PersonEntity:
          Name:
            NameFull: Kon M
      – PersonEntity:
          Name:
            NameFull: Saitoh A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 04
              Text: 2026 Apr 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 79
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1